Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.7k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #653

    E L, in June last year they changed it from 2022 to 2024. Now they have changed it back to 2022. At the same time (June last year) they changed the end of study from maximum up to 5 years to 7 years. But as it is "up to" I guess they have now found out that the 7 years are not necessary.

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #654

      Study start 2015 + 7 = 2022

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #655

        ok, thanks

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #656

          Det bliver der bibob. 🙂

          1 Reply Last reply
          0
          • M Offline
            M Offline
            Mcjean
            wrote on sidst redigeret af
            #657

            Yep 1 bog fuld pris, køb 100 spar 1 hel bogs værdi;-)

            1 Reply Last reply
            0
            • G Offline
              G Offline
              gentogen
              wrote on sidst redigeret af
              #658

              April 10, 2018; 90 (15 Supplement) APRIL 27, 2018
              Anti-CD20 Antibodies Ofatumumab and Ocrelizumab Have Distinct Effects on Human B-cell Survival (S52.003)

              1 Reply Last reply
              0
              • G Offline
                G Offline
                gentogen
                wrote on sidst redigeret af
                #659

                the extent of cell lysis was highest with ofatumumab, followed by rituximab and ocrelizumab. Ongoing studies in other B-cell cytotoxicity assays will provide a broader overview regarding relevant MoAs.

                Conclusions: The strong complement-dependent B-cell lysis by ofatumumab may contribute to its high potency in vivo that enables a low-dose subcutaneous dosing regimen.

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #660

                  Fint, tak gentogen

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #661

                    EMA:
                    The Paediatric Committee (PDCO) adopted opinions agreeing paediatric investigation plans (PIPs) for the following medicines:
                    • Daratumumab, EMEA-002152-PIP01-17, from Janssen-Cilag International N.V., for the treatment of lymphoid malignancies (except mature B-cell neoplasms); http://www.ema.europa.eu/docs/en_GB/document_library/Committee_meeting_report/2018/05/WC500248882.pdf

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #662

                      Recommendations for submission of supplementary information for Dara, signal Encephalopathy, to Assess in the next PSUR (submission by 24 July 2018) - http://www.ema.europa.eu/docs/en_GB/document_library/PRAC_recommendation_on_signal/2018/04/WC500247424.pdf p8

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #663

                        another Tecentriq disappointment in colorectal cancer https://www.reuters.com/article/us-roche-immunotherapy/setback-to-roche-hopes-for-tecentriq-as-fails-key-cancer-trial-idUSKBN1IB16N

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          peter12
                          wrote on sidst redigeret af
                          #664

                          GMXAY lukker i 20,88 eller 1309 ? 😉

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            bikube
                            wrote on sidst redigeret af
                            #665

                            Det bliver da spændende at se, hvad GMXAY så bliver handlet til fredag, hvor dansk børs stadig er lukket.

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #666

                              God morgen. 🙂

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                Plimsoller
                                wrote on sidst redigeret af
                                #667

                                God morgen 🙂

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #668

                                  interesting interview on the MASTER trial - https://myelomacrowd.org/full-show-master-trial/

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #669

                                    and a little bit more background https://uab.edu/news/research/item/9429-uab-recruiting-for-clinical-trial-to-determine-therapies-for-eradication-of-multiple-myeloma#.WvUGNKQQ-wA.twitter http://www.bbc.com/news/health-44070029

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      Plimsoller
                                      wrote on sidst redigeret af
                                      #670

                                      Danke vel 🙂

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #671

                                        😉

                                        1 Reply Last reply
                                        0
                                        • JonSnowJ Offline
                                          JonSnowJ Offline
                                          JonSnow
                                          wrote on sidst redigeret af
                                          #672

                                          Kan man bruge stigningen af GMXAY som indikation for, hvordan Genmab vil udvikle
                                          sig på mandag?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger